Related Experiment Video
Updated: Oct 19, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma
1Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, China; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, China.
Background:
Recurrence and metastasis are the major problems of bladder urothelial carcinoma, which mainly attribute to tumor cell stemness, epithelial-mesenchymal transition (EMT) and chemoresistance.
Methods:
TCGA database was interrogated for gene mRNA expression in bladder urothelial carcinoma samples. CCLE database was interrogated for gene mRNA expression in bladder cancer cell lines. The correlation between two genes was analyzed by Pearson statistics. 37 human bladder urothelial carcinoma specimens were adopted for immunohistochemistry. Bladder cancer cells RT4, J82, and UM-UC-3 were used to carry out loss and gain of function studies. Kaplan-Meier method was performed to analyze the overall survival.
Findings:
WNT7B is downregulated in high-grade bladder urothelial carcinomas. Low WNT7B expression is associated with unfavorable prognosis. Loss and gain of function studies showed that WNT7B inhibits bladder urothelial carcinoma cell EMT, stem-like properties and chemoresistance. FZD5, a specific receptor for WNT7B, mediates WNT7B signaling. ELF3 is a downstream component of WNT7B signaling, which transcriptionally modulates NOTCH1, a tumor suppressor in bladder urothelial carcinoma.
Interpretation:
These data demonstrate that WNT7B/FZD5-ELF3-NOTCH1 signaling functions as a tumor-suppressing pathway in bladder urothelial carcinoma.
Insights
WNT7B acts as a tumor suppressor in bladder cancer by inhibiting cell stemness, EMT, and chemoresistance. This pathway, involving FZD5, ELF3, and NOTCH1, offers a new target for bladder urothelial carcinoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Recurrence and metastasis are critical challenges in bladder urothelial carcinoma.
- Tumor cell stemness, epithelial-mesenchymal transition (EMT), and chemoresistance contribute significantly to these issues.
Purpose of the Study:
- To investigate the role of WNT7B in bladder urothelial carcinoma.
- To elucidate the signaling pathway involving WNT7B, FZD5, ELF3, and NOTCH1.
Main Methods:
- Analysis of TCGA and CCLE databases for gene expression.
- Immunohistochemistry on patient specimens.
- In vitro loss and gain of function studies in bladder cancer cell lines.
- Survival analysis using the Kaplan-Meier method.
Main Results:
- WNT7B is downregulated in high-grade bladder urothelial carcinomas and associated with poor prognosis.
- WNT7B inhibits EMT, stem-like properties, and chemoresistance in bladder cancer cells.
- The WNT7B/FZD5-ELF3-NOTCH1 pathway was identified, with ELF3 modulating the tumor suppressor NOTCH1.
Conclusions:
- WNT7B/FZD5-ELF3-NOTCH1 signaling acts as a tumor-suppressing pathway in bladder urothelial carcinoma.
- This pathway represents a potential therapeutic target for improving patient outcomes.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

